Cathy Tralau-Stewart discusses strengthening UK therapeutic translation in Drug Discovery World
We’re delighted that our Executive Director, Professor Cathy Tralau-Stewart, has continued her thought leadership work with Drug Discovery World, with a timely article on “The role of universities and industry in driving translation of therapeutics: the need for a new...
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
We are thrilled to announce that the Functional Genomics Screening Laboratory (FGSL) has been awarded an OBN Award in the Most Impactful Industry Collaboration category. This recognises the pioneering work taking place in the FGSL — a collaboration between the Milner...
Cathy Tralau-Stewart joins expert panel at 2025 Drug Discovery World Symposium
Milner Executive Director Cathy Tralau-Stewart was delighted to join Drug Discovery World (DDW) at their 2025 Symposium this month, which brought together leaders from drug discovery, academia, and biotech to explore how innovation can move more effectively from...
Milner Therapeutics Institute and Cambridge Network join forces to showcase MTI partnerships and enterprise
Earlier this week, we were delighted to team up with Cambridge Network to host an event at the West Hub in Cambridge. The event provided an overview of the Institute’s unique translational ecosystem, and Cambridge Network members gathered to learn more about the ways...
Milner Institute joins BioCentury’s Grand Rounds Europe conference
The Milner Institute was proud to take part in BioCentury’s Grand Rounds Europe conference in Cambridge this month. Over three days of keynotes, fireside chats, panel discussions and networking sessions, Grand Rounds fostered meaningful dialogue, inspired new ideas,...
Daiichi Sankyo joins Milner Therapeutics Consortium
We are delighted to announce that Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. The Milner team works closely with this unique grouping of pharma companies to advance research towards new therapeutics across multiple disease...
Milner Institute welcomes local MPs to explore research and innovation
Last week, we were delighted to welcome Pippa Heylings MP, Charlotte Cane MP and Councillor Olaf Hauk to the Milner Therapeutics Institute. The visit provided an opportunity to showcase our mission and impact, including our pioneering research, collaborations with...
Milner Head of AI expands role across Milner Institute and Yonsei University
We are delighted to share that Dr Namshik Han, Head of AI and Computational Research at the Milner Therapeutics Institute, has begun a new role as Professor at Yonsei University in Seoul, South Korea. Namshik will divide his time between Yonsei University and the...